Evidence map›Paper›PMID 31288848›Full record

ArticleBMC research notes2019

Prescribing pattern of statins for primary prevention of cardiovascular diseases in patients with type 2 diabetes: insights from Ethiopia.

Gebre Teklemariam Demoz, Shishay Wahdey, Gebremicheal Gebreslassie Kasahun, Kalay Hagazy, Daniel Gebrehawaria Kinfe, Hagos Tasew, Degena Bahrey, Yirga Legesse Niriayo

Open access · goldFull text read
In one paragraph

Article in BMC research notes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Lipid management strategies for diabetic patients align with an evidence-based guideline.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2024
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Determinants of Statin Initiation Among Adult Diabetic Patients in Bonga, Ethiopia.Diabetes, metabolic syndrome and obesity : targets and therapy · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Gebre Teklemariam DemozSchool of Pharmacy, College of Health Sciences, Aksum University, PO.Box: 298, Aksum, Ethiopia. gebretekl@gmail.com.ORCID http://orcid.org/0000-0002-2534-821X
Shishay WahdeySchool of Public Health, Mekelle University, Mekelle, Ethiopia.
Gebremicheal Gebreslassie KasahunSchool of Pharmacy, College of Health Sciences, Aksum University, PO.Box: 298, Aksum, Ethiopia.
Kalay HagazySchool of Pharmacy, College of Health Sciences, Aksum University, PO.Box: 298, Aksum, Ethiopia.
Daniel Gebrehawaria KinfeSchool of Medicine, Aksum University, Aksum, Ethiopia.
Hagos TasewNursing School, Aksum University, Aksum, Ethiopia.
Degena BahreyNursing School, Aksum University, Aksum, Ethiopia.
Yirga Legesse NiriayoSchool of Pharmacy, Mekelle University, Mekelle, Ethiopia.
Aksum University · ETMekelle University · ET

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveAlthough most clinical practice guidelines endorsed statin use in type 2 diabetes (T2D) patients for reducing cardiovascular diseases (CVD), little is known about statin utilization in case of Ethiopia. Hence, this study was aimed to evaluate prescribing pattern of statins for primary prevention of CVD in T2D patients. A retrospective study conducted in T2D patients with the age group of 40-75 years. Prescriptions were audited for details of statin use and dose intensity. Descriptive analysis was performed using SPSS version 22.0.

resultsWe included a total of 323 study subjects. Of those, 55.7% study subjects were found to be received statin for their primary prevention of CVD. Commonly prescribed type of statins was simvastatin (37.2%), atorvastatin (32.8%) and rosuvastatin (15.6%). Low, moderate and high intensive dose of statins were prescribed in 27.8%, 46.1%, and 26.1%, respectively. Of those subjects received statin, 60.6% had on target cholesterol level. Overall, a significant percentage of subjects did not receive their recommended statin for primary prevention of CVD which is below the guidelines' recommendation. Therefore, adherence to guidelines may help to promote the use of statins for primary prevention of CVD in T2D and advance interventions to improve statin prescribing should be considered.

Indexed as

Practice Patterns, Physicians'AdultAgedAtorvastatinCardiovascular DiseasesDiabetes Mellitus, Type 2Drug MonitoringEthiopiaFemaleHumansHydroxymethylglutaryl-CoA Reductase InhibitorsMaleMiddle AgedRetrospective StudiesRosuvastatin CalciumSimvastatinAtorvastatinHydroxymethylglutaryl-CoA Reductase InhibitorsRosuvastatin CalciumSimvastatinEthiopiaPrescribing patternPrimary preventionStatinType 2 diabetes

Identifiers

PMID31288848
PMCPMC6617647
OpenAlexW2956369737

What Socratic holds

Textfull text, public
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.